United States · Bill · S
S. 1008 (115th)
Therapeutic Hemp Medical Access Act of 2017
Introduced
2 May 2017
Last action
—
Status
Read twice and referred to the Committee on the Judiciary.
Sponsors
—
Subjects
Discovery layer
Source updated
10 August 2026
Summary
Therapeutic Hemp Medical Access Act of 2017 This bill amends the Controlled Substances Act (CSA): to add definitions for the terms "cannabidiol," "cannabidiol-rich plants," and "tetrahydrocannabinol concentration"; to exclude cannabidiol and cannabidiol-rich plants from the definition of marijuana; and to remove cannabidiol and cannabidiol-rich plants from coverage under the CSA. It also specifies that no provision of this bill prohibits or restricts the use, production, or distribution of marijuana in a state in which such activities are legal under state law.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate · EN · 2 May 2017
Introduced in Senate (PDF)
Introduced in Senate · EN · 2 May 2017
Introduced in Senate
summary · EN · 2 May 2017
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/115th-congress/senate-bill/1008
- Open data entity: https://api.congress.gov/v3/bill/115/s/1008